Cargando…
The Heart in COVID-19: Primary Target or Secondary Bystander?
In the throes of the current coronavirus disease-2019 (COVID-19) pandemic, interest has burgeoned in the cardiovascular complications of this virulent viral infection. As troponin, a biomarker of cardiac injury, often rises in hospitalized patients, its interpretation and actionability require caref...
Autor principal: | Libby, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151324/ https://www.ncbi.nlm.nih.gov/pubmed/32292847 http://dx.doi.org/10.1016/j.jacbts.2020.04.001 |
Ejemplares similares
-
Multiorgan Damage in Patients With COVID-19: Is the TGF-β/BMP Pathway the Missing Link?
por: Carlson, F. Roy, et al.
Publicado: (2020) -
Variations on fetal heart rate variability
por: Shaw, C. J., et al.
Publicado: (2016) -
Molecular Epidemiology of Heart Failure: Translational Challenges and Opportunities
por: Smith, J. Gustav
Publicado: (2017) -
Bystander Programs: Accommodating or Derailing Sexism?
por: Reid, Adam, et al.
Publicado: (2017) -
Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)